Article
Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus.
Atherosclerosis - 1 Jun 1993
Ukkola O, Kervinen K, Salmela P I, von Dickhoff K, Laakso M, Kesäniemi Y A
Abstract excerpt
The role of apoliprotein E (apo E) in modulating the susceptibility of individuals with non-insulin-dependent diabetes mellitus (NIDDM) to atherosclerotic vascular disease was studied in 143 male and 128 female patients with NIDDM. The data show that the apolipoprotein phenotype E2 somehow protects from macrovascular complications in NIDDM both in men and women. E2 also tends to protect from microvascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.